Literature DB >> 2842712

Expression of the N-myc oncogene in Wilms' tumour and related tissues.

A P Shaw1, V Poirier, S Tyler, M Mott, J Berry, N J Maitland.   

Abstract

Tissue samples and cell cultures from Wilms' tumour matched histologically normal kidney samples and EBV transformed B cells from the same patients, were analysed to detect changes in the structure and expression of the N-myc oncogene. The levels of expression of HLA class I and hypoxanthine guanine phosphoribosyl transferase were also measured in the various RNA preparations. Related tissue samples, from sources including congenital mesoblastic nephroma, paediatric neuroblastoma and a number of foetal tissues were also tested. Northern blot analysis indicated that the levels of N-myc were higher in Wilms' tumour tissues (with no parallel increase in gene copy number) compared to all other sources of material including foetal kidney. Particularly high levels of expression were observed in a number of the Wilms' tumours, several of which produced metastases. In situ hybridization, using [35S]-labelled RNA probes, confirmed that the high levels of N-myc RNA were present in the blastemal elements in the Wilms' tumour. All the tissue cultures, and tissue samples from other sources, except foetal brain and neuroblastoma, contained uniformly low levels of N-myc RNA.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2842712

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  6 in total

1.  Subtype-specific FBXW7 mutation and MYCN copy number gain in Wilms' tumor.

Authors:  Richard D Williams; Reem Al-Saadi; Tasnim Chagtai; Sergey Popov; Boo Messahel; Neil Sebire; Manfred Gessler; Jenny Wegert; Norbert Graf; Ivo Leuschner; Mike Hubank; Chris Jones; Gordan Vujanic; Kathy Pritchard-Jones
Journal:  Clin Cancer Res       Date:  2010-03-23       Impact factor: 12.531

2.  Molecular and epidemiologic characterization of Wilms tumor from Baghdad, Iraq.

Authors:  Hannah M Phelps; Mazin F Al-Jadiry; Natasha M Corbitt; Janene M Pierce; Bingshan Li; Qiang Wei; Raina R Flores; Hernan Correa; Stefania Uccini; Haydar Frangoul; Adel R Alsaadawi; Safaa A F Al-Badri; Amir F Al-Darraji; Raghad M Al-Saeed; Salma A Al-Hadad; Harold N Lovvorn Iii
Journal:  World J Pediatr       Date:  2018-08-28       Impact factor: 2.764

3.  The G401 cell line, utilized for studies of chromosomal changes in Wilms' tumor, is derived from a rhabdoid tumor of the kidney.

Authors:  A J Garvin; G G Re; B I Tarnowski; D J Hazen-Martin; D A Sens
Journal:  Am J Pathol       Date:  1993-02       Impact factor: 4.307

4.  Expression of the 11p13 Wilms' tumor gene, WT1, correlates with histologic category of Wilms' tumor.

Authors:  W L Gerald; T S Gramling; D A Sens; A J Garvin
Journal:  Am J Pathol       Date:  1992-05       Impact factor: 4.307

5.  Transcriptomic Analyses of MYCN-Regulated Genes in Anaplastic Wilms' Tumour Cell Lines Reveals Oncogenic Pathways and Potential Therapeutic Vulnerabilities.

Authors:  Marianna Szemes; Zsombor Melegh; Jacob Bellamy; Ji Hyun Park; Biyao Chen; Alexander Greenhough; Daniel Catchpoole; Karim Malik
Journal:  Cancers (Basel)       Date:  2021-02-06       Impact factor: 6.639

6.  Loss of chromosome 11p alleles in cultured cells derived from Wilms' tumours.

Authors:  K W Brown; A P Shaw; V Poirier; S J Tyler; P J Berry; M G Mott; N J Maitland
Journal:  Br J Cancer       Date:  1989-07       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.